Endocrinology & Metabolism
FDA Approves Tirzepatide for Obstructive Sleep Apnea
Tirzepatide reduced apnea severity and body weight in adults with obesity and moderate-to-severe obstructive sleep apnea, supporting FDA approval with or without ongoing positive airway pressure therapy.
Egbavwe Pela · August 13, 2026 · 7 min